| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.25 | 0.09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 9e-06 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.23 | 0.08 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.22 | 0.0001 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.21 | 0.09 |